These results indicate DNASE1L3 is a potential biomarker for predicting the prognosis of HCC and identify DNASE1L3 as a regulator of tumor microenvironment via impairing the senescence-associated secretory phenotype in response to stress. This evidence concerns the gene DNASE1L3 and hepatocellular carcinoma.